Literature DB >> 33557047

Making the Most of Complexity to Create Opportunities: Comprehensive Genomic Profiling and Molecular Tumor Board for Patients with Non-Small Cell Lung Cancer (NSCLC).

Caterina Fumagalli1, Elena Guerini-Rocco1,2, Massimo Barberis1.   

Abstract

Personalized cancer therapy matches the plan of treatment with specific molecular alterations [...].

Entities:  

Year:  2021        PMID： 33557047      PMCID： PMC7913872          DOI： 10.3390/cancers13040609

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN： 2072-6694            Impact factor:   6.639


  27 in total

1.  Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden.

Authors:  Matthew D Hellmann; Tudor-Eliade Ciuleanu; Adam Pluzanski; Jong Seok Lee; Gregory A Otterson; Clarisse Audigier-Valette; Elisa Minenza; Helena Linardou; Sjaak Burgers; Pamela Salman; Hossein Borghaei; Suresh S Ramalingam; Julie Brahmer; Martin Reck; Kenneth J O'Byrne; William J Geese; George Green; Han Chang; Joseph Szustakowski; Prabhu Bhagavatheeswaran; Diane Healey; Yali Fu; Faith Nathan; Luis Paz-Ares
Journal:  N Engl J Med       Date:  2018-04-16       Impact factor: 91.245

2.  Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board Portal.

Authors:  David Tamborero; Rodrigo Dienstmann; Maan Haj Rachid; Jorrit Boekel; Richard Baird; Irene Braña; Luigi De Petris; Jeffrey Yachnin; Christophe Massard; Frans L Opdam; Richard Schlenk; Claudio Vernieri; Elena Garralda; Michele Masucci; Xenia Villalobos; Elena Chavarria; Fabien Calvo; Stefan Fröhling; Alexander Eggermont; Giovanni Apolone; Emile E Voest; Carlos Caldas; Josep Tabernero; Ingemar Ernberg; Jordi Rodon; Janne Lehtiö
Journal:  Nat Med       Date:  2020-07-06       Impact factor: 53.440

3.  Letter to the Editor.

Authors:  Caterina Fumagalli; Chiara Casadio; Massimo Barberis; Juliana Guarize; Elena Guerini-Rocco
Journal:  Clin Lung Cancer       Date:  2018-03-12       Impact factor: 4.785

4.  Feasibility of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Cytology Specimens for Next Generation Sequencing in Non-small-cell Lung Cancer.

Authors:  Sean P Stoy; Jeremy P Segal; Jeffrey Mueller; Larissa V Furtado; Everett E Vokes; Jyoti D Patel; Septimiu Murgu
Journal:  Clin Lung Cancer       Date:  2017-12-05       Impact factor: 4.785

5.  Molecular and Genomic Profiling of Lung Cancer in the Era of Precision Medicine: A Position Paper from the Italian Association of Thoracic Oncology (AIOT).

Authors:  Nicola Normanno; Massimo Barberis; Filippo De Marinis; Cesare Gridelli
Journal:  Cancers (Basel)       Date:  2020-06-19       Impact factor: 6.639

6.  Establishment of a Molecular Tumor Board (MTB) and Uptake of Recommendations in a Community Setting.

Authors:  Ari VanderWalde; Axel Grothey; Daniel Vaena; Gregory Vidal; Adam ElNaggar; Gabriella Bufalino; Lee Schwartzberg
Journal:  J Pers Med       Date:  2020-11-27

7.  Rationale and Design of the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Authors:  Pam K Mangat; Susan Halabi; Suanna S Bruinooge; Elizabeth Garrett-Mayer; Ajjai Alva; Katherine A Janeway; Philip J Stella; Emile Voest; Kathleen J Yost; Jane Perlmutter; Navin Pinto; Edward S Kim; Richard L Schilsky
Journal:  JCO Precis Oncol       Date:  2018-07-11

8.  Impact and Diagnostic Gaps of Comprehensive Genomic Profiling in Real-World Clinical Practice.

Authors:  Aditi P Singh; Elaine Shum; Lakshmi Rajdev; Haiying Cheng; Sanjay Goel; Roman Perez-Soler; Balazs Halmos
Journal:  Cancers (Basel)       Date:  2020-05-04       Impact factor: 6.639

9.  Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancer.

Authors:  Samantha O Perakis; Sabrina Weber; Qing Zhou; Ricarda Graf; Sabine Hojas; Jakob M Riedl; Armin Gerger; Nadia Dandachi; Marija Balic; Gerald Hoefler; Ed Schuuring; Harry J M Groen; Jochen B Geigl; Ellen Heitzer; Michael R Speicher
Journal:  ESMO Open       Date:  2020-09

10.  Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations.

Authors:  Bart Koopman; Harry J M Groen; Marjolijn J L Ligtenberg; Katrien Grünberg; Kim Monkhorst; Adrianus J de Langen; Mirjam C Boelens; Marthe S Paats; Jan H von der Thüsen; Winand N M Dinjens; Nienke Solleveld; Tom van Wezel; Hans Gelderblom; Lizza E Hendriks; Ernst-Jan M Speel; Tom E Theunissen; Leonie I Kroeze; Niven Mehra; Berber Piet; Anthonie J van der Wekken; Arja Ter Elst; Wim Timens; Stefan M Willems; Ruud W J Meijers; Wendy W J de Leng; Anne S R van Lindert; Teodora Radonic; Sayed M S Hashemi; Daniëlle A M Heideman; Ed Schuuring; Léon C van Kempen
Journal:  Oncologist       Date:  2020-11-10
View more
  1 in total

1.  Diagnostic and Predictive Biomarkers in Lung Cancer.

Authors:  Caterina Fumagalli; Massimo Barberis
Journal:  Cancers (Basel)       Date:  2021-05-25       Impact factor: 6.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.